Hyoscine-N-Butyl Bromide Market Competition Tracking- Key Market Insights 2018-2027 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Hyoscine-N-Butyl Bromide Market Competition Tracking- Key Market Insights 2018-2027

Description:

The Hyoscine-N-Butyl Bromide market was valued at over US$ 50 million in 2018 and is projected to register Y-O-Y growth of 4.3% in 2019. – PowerPoint PPT presentation

Number of Views:8

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Hyoscine-N-Butyl Bromide Market Competition Tracking- Key Market Insights 2018-2027


1
Hyoscine-N-Butyl Bromide Market Forecast, Trend
Analysis Competition Tracking- Global Market
Insights 2018-2027
  • Chemical Materials
  • 17O Pages
  • Published Mar 2019

2
Market Snapshot
3
Description
  • Hyoscine-N-Butyl Bromide used to treat abdominal
    pain and spasms is available in both oral and
    injectable form. However, with increasing sales
    of Hyoscine-N-Butyl Bromide under the brandname
    Buscopan which is an oral medication, the
    application of Hyoscine-N-Butyl Bromide in oral
    form is gaining traction. Moreover, with a range
    of benefits on oral administration of
    Hyoscine-N-Butyl Bromide, it is being used on a
    large scale. Upon oral administration, it binds
    and blocks muscarinic receptors, thereby,
    providing anti-spasmodic effect in the uterine,
    gastrointestinal, and urinary tracts. 
  • The report on the Hyoscine-N-Butyl Bromide market
    serves as an authentic dataset for readers and
    players to plan business strategies in order to
    stay competitive in the Hyoscine-N-Butyl Bromide
    market.   

4
Hyoscine-N-Butyl Bromide Market- Key Insights
  • Worldwide sales of Hyoscine-N-Butyl Bromide
    recorded a steady growth by registering 4.0 CAGR
    between 2013 and 2017. However, the market is
    likely to witness significant growth in the
    coming years owing to its wide application in
    treating various conditions and acting as muscle
    relaxant.
  • The Hyoscine-N-Butyl Bromide market was valued at
    over US 50 million in 2018 and is projected to
    register Y-O-Y growth of 4.3 in 2019.
  • Europe is expected to be the largest region in
    the Hyoscine-N-Butyl Bromide market during the
    forecast period and account for an estimated
    34.6 share by 2019 end.

5
Assessment of Competitive Landscape
  • Boehringer Ingelheim has filed for the regulatory
    approval of Nintedanib for patients with systemic
    sclerosis associated interstitial lung disease
    with the EMA and FDA. Recently, Boehringer also
    entered into a research collaboration with GNA
    Biosolutions to develop emergency veterinary
    diagnostics, including rapid diagnostic test for
    African swine fever that can be used on the
    portable molecular diagnostic platform by GNA.
  • The FDA has approved Dicyclomine HCl Injection,
    the generic version of Bentyl Injection by
    Aptalis Pharma. Dicyclomine HCl is an
    anti-spasmodic and anti-cholinergic agent that
    helps to relieve smooth muscle spasms in the
    gastrointestinal tract. The injection is supplied
    as 20mg/2ml.

6
Table of Contents
  • 1. Global Hyoscine-N-Butyl Bromide Market -
    Executive Summary
  • 2. Global Hyoscine-N-Butyl Bromide Market
    Overview     2.1. Introduction           
    2.1.1. Global Hyoscine-N-Butyl Bromide Market
    Taxonomy            2.1.2. Global
    Hyoscine-N-Butyl Bromide Market Definition   
     2.2. Global Hyoscine-N-Butyl Bromide Market Size
    (US Mn) and Forecast, 2013-2027           
    2.2.1. Global Hyoscine-N-Butyl Bromide Market
    Y-o-Y Growth     2.3. Global Hyoscine-N-Butyl
    Bromide Market Dynamics     2.4. Supply Chain 
       2.5. Cost Structure     2.6. Pricing
    Analysis      2.7. Raw Material Sourcing
    Strategy and Analysis     2.8. Service Provider
    List     2.9. Key Participants Market Presence
    (Intensity Map) By Region

7
  • 3. Global Hyoscine-N-Butyl Bromide Market
    Analysis and Forecast 2013-2027      3.1. Global
    Hyoscine-N-Butyl Bromide Market Size and Forecast
    By Application, 2013-2027            3.1.1. Oral
    Market Size and Forecast, 2013-2027             
           3.1.1.1. Revenue (US Mn) Comparison, By
    Region                     3.1.1.2. Market Share
    Comparison, By Region                   
     3.1.1.3. Y-o-Y growth Comparison, By Region   
            3.1.2. Injectables Market Size and
    Forecast, 2013-2027                     3.1.2.1.
    Revenue (US Mn) Comparison, By Region         
               3.1.2.2. Market Share Comparison, By
    Region                     3.1.2.3. Y-o-Y growth
    Comparison, By Region
  • 4. North America Hyoscine-N-Butyl Bromide Market
    Size and Forecast, 2013-2027     4.1. Revenue
    (US Mn) Comparison, By Country      4.2.
    Revenue (US Mn) Comparison, By Application 

8
  • Scope
  • The scope of Fact.MRs report is to analyze the
    Hyoscine-N-Butyl Bromide market for the forecast
    period 2018-2027 and provide readers an unbiased
    and accurate analysis. Hyoscine-N-Butyl Bromide
    manufacturers, stakeholders, and suppliers
    involved in the Hyoscine-N-Butyl Bromide market
    can benefit from the analysis offered in this
    report. This report offers a comprehensive
    analysis, which can be of interest to incumbent
    players and new entrants looking to enter the
    Hyoscine-N-Butyl Bromide market.
  • Summary
  • The report commences with a brief information of
    the Hyoscine-N-Butyl Bromide market. This
    executive summary sets the tone for the rest of
    the report, providing users the scope of the
    report. The executive summary includes important
    facts and statistics on the Hyoscine-N-Butyl
    Bromide market.

Request Free Sample Report
9
Get In Touch
  • Want Tailor-made Report?
  • Enquire at sales_at_factmr.com Now!
  • Suite 9884 27 Upper Pembroke Street,
    Dublin 2, Ireland
  • Toll Free 353-1-6111-593Email
    sales_at_factmr.comWebsite https//www.factmr.com/
About PowerShow.com